rare disease data center
Tracking ARC vs Rare Disease Data Center Surge
Tracking ARC vs Rare Disease Data Center Surge 35% more FDA approvals have flowed from the ARC program than from the Rare Disease Data Center’s patient-record expansion, marking the fastest surge in rare-disease therapeutics to date. I have seen families move from endless waiting to receiving a targeted therapy